Bank of New York Mellon Corp Sells 227,357 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Bank of New York Mellon Corp cut its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) by 8.8% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,359,850 shares of the company's stock after selling 227,357 shares during the period. Bank of New York Mellon Corp owned about 1.97% of Privia Health Group worth $46,135,000 as of its most recent SEC filing.

Other large investors have also bought and sold shares of the company. Nordea Investment Management AB raised its stake in shares of Privia Health Group by 33.1% during the 4th quarter. Nordea Investment Management AB now owns 349,773 shares of the company's stock worth $6,953,000 after purchasing an additional 86,910 shares during the period. Victory Capital Management Inc. raised its stake in shares of Privia Health Group by 402.9% during the 3rd quarter. Victory Capital Management Inc. now owns 179,049 shares of the company's stock worth $3,260,000 after purchasing an additional 143,446 shares during the period. Franklin Resources Inc. raised its stake in shares of Privia Health Group by 2.2% during the 3rd quarter. Franklin Resources Inc. now owns 1,300,240 shares of the company's stock worth $23,092,000 after purchasing an additional 28,480 shares during the period. Barclays PLC raised its stake in shares of Privia Health Group by 240.3% during the 3rd quarter. Barclays PLC now owns 224,018 shares of the company's stock worth $4,079,000 after purchasing an additional 158,188 shares during the period. Finally, JPMorgan Chase & Co. raised its stake in shares of Privia Health Group by 8.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 188,384 shares of the company's stock worth $3,430,000 after purchasing an additional 14,641 shares during the period. 94.48% of the stock is currently owned by institutional investors.

Remove Ads

Privia Health Group Stock Performance

PRVA stock traded up $0.28 on Friday, reaching $25.54. The company's stock had a trading volume of 903,724 shares, compared to its average volume of 750,855. The business has a fifty day simple moving average of $22.94 and a two-hundred day simple moving average of $20.79. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $26.04. The firm has a market cap of $3.08 billion, a PE ratio of 255.43, a PEG ratio of 3.47 and a beta of 0.85.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the company. Macquarie began coverage on Privia Health Group in a research note on Monday, December 16th. They issued an "outperform" rating and a $25.00 price objective on the stock. Piper Sandler upped their price objective on shares of Privia Health Group from $25.00 to $40.00 and gave the stock an "overweight" rating in a research report on Friday, February 28th. JPMorgan Chase & Co. upped their price objective on shares of Privia Health Group from $27.00 to $28.00 and gave the stock an "overweight" rating in a research report on Friday, November 29th. Stephens reiterated an "overweight" rating and set a $26.00 price target on shares of Privia Health Group in a research report on Thursday, January 2nd. Finally, Canaccord Genuity Group increased their price target on shares of Privia Health Group from $29.00 to $30.00 and gave the company a "buy" rating in a research report on Friday, February 28th. One analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Buy" and a consensus target price of $26.47.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.